期刊文献+

动态血压监测氨氯地平合用依那普利治疗中度高血压病分析

Evalution the effect of amlodipine besylate tablets combined enalapril maleate tablets on the treatment of moderate essential hypertension by using ABPM technology
下载PDF
导出
摘要 目的利用动态血压监测(ABPM)技术评价苯磺酸氨氯地平合用马来酸依那普利治疗中度原发性高血压(EH)的疗效。方法 52例中度EH者未服或停用其他降压药2w以上,给予氨氯地平5mgqd,依那普利10mgqd顿服6w所有患者治疗前后均进行ABPM。结果 52例经治疗6w后ABPM明显降低,总有效率90.38%。结论对中度EH氨氯地平合用依那普利能达到24h平稳降压。 Objective Evalution the effect of amlodipine besylate tablets combined enalapril maleate tablets on the treatment of moderate essential hypertension(EH) by using ABPM technology.Methods 52 patients with moderate essential hypertension,who didn't take medicine or withdrew other antihypertensive drugs for more than 2 weeks,were given amlodipine besylate tablets 5mg qd and enalapril maleate tablets 10mg qd for 6 weeks.All patients were monitored by ABPM.before and after treatment.Results Ambulatory blood pressure of all the 52 cases decreased after 6 weeks of treatment,the total effective rate was 90.38%.Conclusion The patients with moderate essential hypertension treated with combination of Amlodipine Besylate tablets with Enalapril Maleate tablets can achieve a smooth 24-hour blood pressure.
作者 张建生
出处 《实用心电学杂志》 2010年第5期343-344,共2页 Journal of Practical Electrocardiology
  • 相关文献

参考文献4

二级参考文献19

  • 1刘力生.2004年中国高血压防治指南(实用本)[J].中华心血管病杂志,2004,32(12):1060-1064. 被引量:2620
  • 2全国血压抽样调查协作组.中国人群高血压患病率及其变化趋势[J].高血压杂志,1995,3(A01):7-13. 被引量:508
  • 3胡春松,高润霖,刘力生.高血压治疗的七大原则[J].中国中西医结合杂志,2006,26(4):363-365. 被引量:29
  • 4陈才顺.高血压联合用药治疗现状与展望[J].中国医药导报,2007,4(04S):93-93. 被引量:24
  • 5陈丽萍,唐尚中.厄贝沙坦治疗老年原发性高血压的临床疗效观察[J].临床心血管病杂志,2007,23(5):388-389. 被引量:26
  • 6DUCHAME A, SWEDBERG K, PFEFFER M A, et al. Prevention of atrial fibrillation candesartan in heart failure: assessment of reduction in mortality and morbidity (CHARM) program[J]. Am Heart J,2006, 152:86-92.
  • 7OKAZAKI H, MINAMINO T, TSUKAMOTO O, et al. Angiotensin Ⅱ type 1 receptor blocker prevents at rial structural remodeling in rats with hypertension induced by chronic nitric oxide inhibition[J]. Hypertens Res,2006,29:277-284.
  • 8YOUNG J B,DUNLAP M E, PFEFFER M A , et al. Mortality and morbidity reduction with candesartan in patients with CHF and left ventricular systolic dysfunction results of the CHARM low -left ventricular ejection fraction trial [J]. Circulation, 2004, 110: 2618-2626.
  • 9胡春松 胡大一.健康的“种子”法则[J].太平洋论坛杂志,2005,1(6):76-76.
  • 10Chobanian AV, Bakris GL, Black HR, et al. The Seventh Report of the Joint National Committee on Prevention, Detection,Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA 2003 ; 289 (19) : 2560-2572.

共引文献76

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部